Eliem Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$35,119,000 over the previous period. Total operating expenses were $37,408,000.
Profit Margin
| 2019 | 0 | -3.79M | |
|---|---|---|---|
| 2020 | 0 | -11.51M | |
| 2021 | 0 | -47.48M | |
| 2022 | 0 | -45.35M | |
| 2023 | 0 | -35.11M |
ELYM Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 15.41M | 26.21M | 23.32M | 9.34M | 4.01M |
Selling and marketing | 24.85M | 0 | 0 | 0 | 0 |
Total operating expenses | 37.40M | 45.13M | 35.67M | 11.76M | 4.69M |
Operating income | -21.46M | -45.13M | -35.67M | -20.92M | -7.44M |
Other income (expenses), net | -13.65M | -109K | -11.80M | 257K | 899K |
Income before tax | -35.11M | -45.24M | -47.48M | -20.66M | -6.54M |
Income tax expense | -21.46K | 109K | 0 | -9.15M | -2.75M |
Net income | -35.11M | -45.35M | -47.48M | -11.51M | -3.79M |
Earnings per share | |||||
Basic EPS | -1.3 | -1.72 | -1.81 | -0.44 | -0.14 |
Diluted EPS | -1.3 | -1.72 | -1.81 | -0.44 | -0.14 |
| Data source | Data source | Data source |